HIV i-Base

Xmas and New Year opening hours

i-Base will run a reduced treatment information service between Christmas and the New Year. If you have an urgent enquiry during this period, please contact your clinic. The phoneline will be closed between 23rd December and 4th January. We will …

November/December HTB now online

News and reports to challenge HIV treatment and prevention strategies for 2016… EACS 2015, access, guidelines, PrEP

Pocket side effect guide (2015)

  This pocket ART page links to different i-Base resources about side effects, other health problems and your quality of life. Pocket side effects guide is a small i-Base leaflet about side effects, long term health and your quality of life (QoL). Everyone …

Pocket pregnancy guide (2015)

This page links to i-Base resources about HIV and pregnancy. Pocket pregnancy guide is a small i-Base leaflet about HIV and pregnancy. It includes information about planning your pregnancy, using ART, delivery and after care including feeding. This includes a focus on …

New WHO guidelines for when to start ART and use of PrEP (September 2015)

This article is also included in the September/October issue of HTB. http://i-base.info/htb/28949 Simon Collins, HIV i-Base On 30 September 2015, the World Health Organization (WHO) issued a new 78-page guideline document on two important changes to current treatment recommendations. [1, 2] The …

July/August HTB now online

IAS 2015 – a time of global change for HIV care: over a dozen reports on why this conference news is so exciting…

IAS 2015: news from the Vancouver HIV conference

START results in full, WHO recommends ART for all, HIV cure research, webcasts access, treatment as prevention in HPTN 052, HIV remission in a teenager, dispersible dolutegravir for kids, new ARVs and more…

2015 pipeline report

Activist review of latest research into HIV, HCV and TB: drugs for adults and children, dose optimisation, diagnostics, prevention, cure and vaccines…

May/June HTB now online

Remembering Professor Martin Fisher, breaking news on the START study, reports from BHIVA, CROI and HIV & Women conferences and much more…

i-Base Q&A on the START study results

What is the START study? The START study is a large international HIV study. It looks at the risks and benefit of early HIV treatment. “Early” is defined as having a CD4 count above 500. Results are compared to a …

March/April HTB now online

News, comment and reviews of more than 50 studies in 16 articles from CROI 2015 and 4 from the International Drug Resistance Workshop…

Post navigation